Results

Total Results: 455 records

Showing results for "malignant neoplasm".

41. Delay in Malignancy Diagnosis Reflects Systemic Failures | PSNet
    psnet.ahrq.gov/web-mm/delay-malignancy-diagnosis-reflects-systemic-failures
    September 25, 2019 - Delay in Malignancy Diagnosis Reflects Systemic Failures. PSNet [internet]. … section examination of the tissue by the bone pathologist was inconclusive, with potential concern for neoplasm … orthopedic surgery service or inform his colleagues about the status of the case or his concern for neoplasm … Diagnostic accuracy of frozen section in musculoskeletal tumors. … Role of intraoperative pathology consultation in skeletal tumors and tumor-like lesions.

42. Ccscategorynames Fulllabels (pdf file)
    hcup-us.ahrq.gov/toolssoftware/ccs/CCSCategoryNames_FullLabels.pdf
    October 07, 2016 - myeloma 41 Cancer; other and unspecified primary 42 Secondary malignancies 43 Malignant neoplasm without … Other secondary malignancy 2.13 Malignant neoplasm without specification of site [43] 2.14 Neoplasms … neoplasms 2.16.1 Benign neoplasm of uterus [46] 2.16.2 Other and unspecified benign neoplasm [47] 2.16.2.1 … Benign neoplasm of ovary 2.16.2.2 Benign neoplasm of colon 2.16.2.3 Benign neoplasm of the thyroid 2.16.2.4 … Benign neoplasm of cerebral meninges 2.16.2.5 Other and unspecified benign neoplasms 3 Endocrine; nutritional

43. Exhibit 4.3 Average Length of Stay and Average Charges
    hcup-us.ahrq.gov/reports/factsandfigures/figures/2006/2006_4_3.jsp
    January 01, 2006 - 3.5 18,027 Thyroid disorders 2.7 18,032 Epilepsy, convulsions 3.6 18,074 Benign … endocrine, and metabolic disorders 3.6 31,256 Digestive congenital anomalies 5.9 31,655 Malignant … neoplasm without specification of site 7.6 31,798 Other benign neoplasm 4.4 31,832 … conditions 7.4 33,152 Paralysis 7.6 33,230 Chronic renal failure 5.3 33,422 Neoplasms … of other urinary organs 6.2 38,019 Secondary malignancies 7.1 38,140 Osteoarthritis

44. DXCCSR-vs-Beta-CCS-Comparison (pdf file)
    hcup-us.ahrq.gov/toolssoftware/ccsr/DXCCSR-vs-Beta-CCS-Comparison.pdf
    January 01, 2020 - NEO070 Secondary malignancies 6 6 0 43 Malignant neoplasm without specification of site NEO071 Malignant … neoplasm, unspecified 10 9 1 47 Other and unspecified benign neoplasm NEO073 Benign neoplasms 9 1 … NEO070 – Secondary malignancies 43 Malignant neoplasm without specification of site 3 NEO066 – Malignant … neoplasm of uterus 1 NEO073 – Benign neoplasms 47 Other and unspecified benign neoplasm 3 NEO073 – … Benign neoplasms 48 Thyroid disorders 3 END001 – Thyroid disorders 49 Diabetes mellitus without complication

45. Statistical Brief #22
    hcup-us.ahrq.gov/reports/statbriefs/sb22.jsp
    January 22, 2007 - Hospital stays for cervical cancer and all female-specific cancers had comparable lengths of stay (3.7 … Malignant neoplasm of cervix uteri (endocervix) – 180.1 Malignant neoplasm of cervix uteri (exocervix … ) – 180.8 Malignant neoplasm of cervix uteri (other specified sites of cervix) – 180.9 Malignant … Hospital stays for cervical cancer compared with hospital stays for all female-specific cancers, 2004 … *   Hospital stays for cervical cancer Hospital stays for all female-specific cancers Number

46. HCUP Statistical Brief #22: Hospital Stays for Cervical Cancer, 2004 (pdf file)
    hcup-us.ahrq.gov/reports/statbriefs/sb22.pdf
    January 01, 2007 - Hospital stays for cervical cancer and all female-specific cancers had comparable lengths of stay (3.7 … Malignant neoplasm of cervix uteri (endocervix) – 180.1 Malignant neoplasm of cervix uteri (exocervix … ) – 180.8 Malignant neoplasm of cervix uteri (other specified sites of cervix) – 180.9 Malignant neoplasm … Hospital stays for cervical cancer compared with hospital stays for all female-specific cancers, 2004 … * Hospital stays for cervical cancer Hospital stays for all female-specific cancers Number

47. Archived: Brief Evidence Update: Oral Cancer: Screening | United States Preventive Services Taskforce
    www.uspreventiveservicestaskforce.org/uspstf/document/evidence-update-2004/oral-cancer-screening-2004
    February 04, 2004 - The MEDLINE® search strategy combined the exploded MeSH® heading of Oral Neoplasm with Lip Neoplasm, … Tongue Neoplasm, and Pharynx Neoplasm and crossed the result with Mass Screening, yielding 88 articles … Forty-seven cancers (7 resultant deaths) were diagnosed in the intervention group and 16 cancers (9 resultant … Treatment of oral leucoplast, a form of pre malignancy, has been studied in RCT's with several modalities … Micronuclei, a biomarker for chemoprevention trials: results of a randomized study in oral pre-malignancy

48. Maskedstats Nrd 2020 Core Weighted (pdf file)
    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2020_Core_Weighted.PDF
    January 01, 2020 - W MCC 32,499 0.10% 180: RESPIRATORY NEOPLASMS WITH MCC 10,248 0.03% 181: RESPIRATORY NEOPLASMS W CC … 16,395 0.05% 181: RESPIRATORY NEOPLASMS WITH CC 5,009 0.02% 182: RESPIRATORY NEOPLASMS W/O CC/MCC … AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC 5,231 0.02% 659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM … & URETER PROCEDURES FOR NON-NEOPLASM W CC 44,512 0.14% 660: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM … TRACT NEOPLASMS W CC 3,962 0.01% 687: KIDNEY AND URINARY TRACT NEOPLASMS WITH CC 1,357 0.00% 688:

49. Kid 2022 Maskedstats Core Weighted (pdf file)
    hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2022_MaskedStats_Core_Weighted.PDF
    January 01, 2022 - WITH MCC 113 0.00% 181: RESPIRATORY NEOPLASMS WITH CC 110 0.00% 182: RESPIRATORY NEOPLASMS WITHOUT … WITH MCC 116 0.00% 657: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC 356 0.01% 658: KIDNEY AND … URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC 224 0.00% 659: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM … WITH MCC 463 0.01% 660: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC 2,320 0.04% 661: KIDNEY … AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC 3,665 0.06% 662: MINOR BLADDER PROCEDURES WITH

50. Maskedstats Nrd 2022 Core Weighted (pdf file)
    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2022_Core_Weighted.PDF
    January 01, 2022 - WITH MCC 6,519 0.02% 657: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC 20,880 0.06% 658: KIDNEY … AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC 19,551 0.06% 659: KIDNEY AND URETER PROCEDURES FOR … NON-NEOPLASM WITH MCC 26,214 0.08% 660: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC 63,128 … 0.19% 661: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC 60,251 0.18% 662: MINOR BLADDER … IMMUNOLOG DISORD 411,875 1.25% 17: MYELOPROLIFERATIVE DISEASES & DISORDERS, POORLY DIFFERENTIATED NEOPLASM

51. Neds 2018 Ip Maskedstats (pdf file)
    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2018_IP_MaskedStats.PDF
    January 01, 2018 - W MCC 9,775 0.19 181: RESPIRATORY NEOPLASMS W CC 5,616 0.11 182: RESPIRATORY NEOPLASMS W/O CC/MCC … & URETER PROCEDURES FOR NON-NEOPLASM W CC 3,699 0.07 661: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM … W MCC 902 0.02 687: KIDNEY & URINARY TRACT NEOPLASMS W CC 1,324 0.03 688: KIDNEY & URINARY TRACT NEOPLASMS … W MCC 9,778 0.19 181: RESPIRATORY NEOPLASMS W CC 5,616 0.11 182: RESPIRATORY NEOPLASMS W/O CC/MCC … & URETER PROCEDURES FOR NON-NEOPLASM W CC 3,700 0.07 661: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM

52. Neds 2017 Ip Maskedstats (pdf file)
    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2017_IP_MaskedStats.PDF
    January 01, 2017 - W MCC 8,341 0.18 181: RESPIRATORY NEOPLASMS W CC 5,401 0.11 182: RESPIRATORY NEOPLASMS W/O CC/MCC … FOR NEOPLASM W/O CC/MCC 62 0.00 659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 587 0.01 660 … : KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W CC 1,632 0.03 661: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM … FOR NEOPLASM W/O CC/MCC 62 0.00 659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 590 0.01 660 … : KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W CC 1,631 0.03 661: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM

53. Maskedstats Nrd 2020 Core (pdf file)
    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2020_CORE.PDF
    January 01, 2020 - W MCC 18,296 0.11% 180: RESPIRATORY NEOPLASMS WITH MCC 5,848 0.04% 181: RESPIRATORY NEOPLASMS W CC … 9,251 0.06% 181: RESPIRATORY NEOPLASMS WITH CC 2,902 0.02% 182: RESPIRATORY NEOPLASMS W/O CC/MCC 719 … AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC 2,970 0.02% 659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM … & URETER PROCEDURES FOR NON-NEOPLASM W CC 24,233 0.15% 660: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM … & URINARY TRACT NEOPLASMS W/O CC/MCC 386 0.00% 688: KIDNEY AND URINARY TRACT NEOPLASMS WITHOUT CC/MCC

54. Kid 2022 Maskedstats Core (pdf file)
    hcup-us.ahrq.gov/db/nation/kid/tools/stats/KID_2022_MaskedStats_Core.PDF
    January 01, 2022 - WITH MCC 83 0.00% 181: RESPIRATORY NEOPLASMS WITH CC 80 0.00% 182: RESPIRATORY NEOPLASMS WITHOUT CC … WITH MCC 85 0.00% 657: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC 261 0.01% 658: KIDNEY AND … URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC 164 0.01% 659: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM … WITH MCC 339 0.01% 660: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC 1,703 0.06% 661: KIDNEY … AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC 2,693 0.09% 662: MINOR BLADDER PROCEDURES WITH

55. Maskedstats Nrd 2022 Core (pdf file)
    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2022_CORE.PDF
    January 01, 2022 - WITH MCC 3,394 0.02% 657: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC 11,057 0.07% 658: KIDNEY … AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC 10,665 0.06% 659: KIDNEY AND URETER PROCEDURES FOR … NON-NEOPLASM WITH MCC 13,961 0.08% 660: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC 33,521 … 0.20% 661: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITHOUT CC/MCC 32,453 0.20% 662: MINOR BLADDER … IMMUNOLOG DISORD 212,740 1.29% 17: MYELOPROLIFERATIVE DISEASES & DISORDERS, POORLY DIFFERENTIATED NEOPLASM

56. Microsoft Word - Table1-FY2009-V3_4.doc (pdf file)
    hcup-us.ahrq.gov/toolssoftware/comorbidity/Table1-FY2009-V3_4.pdf
    April 01, 2009 - relapse Lymphoma 203.12 Plasma cell leukemia, in relapse Lymphoma 203.82 Other immunoproliferative neoplasms … Solid tumor without metastasis 209.01 Malignant carcinoid tumor of the duodenum Solid tumor without … Malignant carcinoid tumor of the ileum Solid tumor without metastasis 209.10 Malignant carcinoid tumor … tumor of the appendix Solid tumor without metastasis 209.12 Malignant carcinoid tumor of the cecum … Solid tumor without metastasis 209.13 Malignant carcinoid tumor of the ascending colon Solid tumor

57. Neds 2016 Ip Maskedstats (pdf file)
    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2016_IP_MaskedStats.PDF
    January 01, 2016 - W MCC 7,521 0.17 181: RESPIRATORY NEOPLASMS W CC 5,603 0.13 182: RESPIRATORY NEOPLASMS W/O CC/MCC … FOR NEOPLASM W/O CC/MCC 85 0.00 659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 1,491 0.03 … W MCC 605 0.01 687: KIDNEY & URINARY TRACT NEOPLASMS W CC 1,053 0.02 688: KIDNEY & URINARY TRACT NEOPLASMS … W MCC 7,524 0.17 181: RESPIRATORY NEOPLASMS W CC 5,603 0.13 182: RESPIRATORY NEOPLASMS W/O CC/MCC … FOR NEOPLASM W/O CC/MCC 85 0.00 659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 1,497 0.03

58. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare.ahrq.gov/sites/default/files/pdf/stem-cell-children_research-protocol.pdf
    November 01, 2010 - For example, the literature for the use of HSCT in the hematologic malignancies is relatively robust … long-term effects (e.g., growth and development, cognitive ability, future fertility, and secondary malignancies … Malignant Solid Tumors (Key Questions 1 and 2) P: Pediatric patients with malignant solid tumors including … "[Mesh] OR (wilm* AND (tumor OR tumors OR tumour*)) 10:49:05 11596 #32 Search "therapeutic use … Search #72 NOT #5 11:24:57 3127 #72 Search (#70 AND #49) AND #32 11:20:04 3295 #70 Search ("Neoplasms

59. Neds 2015Q4 Ip Maskedstats (pdf file)
    hcup-us.ahrq.gov/db/nation/neds/stats/NEDS_2015Q4_IP_MaskedStats.PDF
    October 01, 2015 - W MCC 1,821 0.17 181: RESPIRATORY NEOPLASMS W CC 1,455 0.14 182: RESPIRATORY NEOPLASMS W/O CC/MCC … FOR NEOPLASM W/O CC/MCC 12 0.00 659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 290 0.03 660 … : KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W CC 823 0.08 661: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM … FOR NEOPLASM W/O CC/MCC 12 0.00 659: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W MCC 291 0.03 660 … : KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM W CC 823 0.08 661: KIDNEY & URETER PROCEDURES FOR NON-NEOPLASM

60. Maskedstats Nrd 2021 Core Weighted (pdf file)
    hcup-us.ahrq.gov/db/nation/nrd/stats/MaskedStats_NRD_2021_Core_Weighted.PDF
    January 01, 2021 - WITH MCC 44,560 0.13% 181: RESPIRATORY NEOPLASMS WITH CC 20,535 0.06% 182: RESPIRATORY NEOPLASMS WITHOUT … EXCEPT MALIGNANCY WITH CC 129,453 0.39% 440: DISORDERS OF PANCREAS EXCEPT MALIGNANCY WITHOUT CC/MCC … WITH MCC 6,576 0.02% 657: KIDNEY AND URETER PROCEDURES FOR NEOPLASM WITH CC 20,638 0.06% 658: KIDNEY … AND URETER PROCEDURES FOR NEOPLASM WITHOUT CC/MCC 20,240 0.06% 659: KIDNEY AND URETER PROCEDURES FOR … NON-NEOPLASM WITH MCC 23,347 0.07% 660: KIDNEY AND URETER PROCEDURES FOR NON-NEOPLASM WITH CC 63,008